{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:35:30Z","timestamp":1792427730394,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"department of science and technology of sichuan province","doi-asserted-by":"crossref","award":["No.2020JDRC0025"],"award-info":[{"award-number":["No.2020JDRC0025"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Primary splenic cancers represent a small number of cancer cases and studies on its clinicopathological features and outcomes are limited. Splenic lymphomas and primary splenic angiosarcoma (PSA) are the 2 most common histological types of splenic cancers. This population-based study aimed to investigate the clinical characteristics and survival outcomes of patients with splenic lymphomas or PSA.<\/jats:p>\n                    <jats:p>Patients diagnosed with splenic lymphomas or PSA between 2000 and 2015 were identified from the Surveillance Epidemiology and End Results database of the National Cancer Institutes. Overall survival (OS) and cancer-specific survival (CSS) rates were calculated using the Kaplan\u2013Meier method. A Cox proportional hazard models were used to identify independent predictors of cancer-specific mortality.<\/jats:p>\n                    <jats:p>A total of 700 patients with splenic lymphoma and 48 patients with PSA were included in this study. The median age of patients with splenic lymphoma was 65\u200ayears and 57\u200ayears for patients with PSA. For patients with splenic lymphoma, the most prevalent histological subtypes were splenic marginal zone lymphoma and diffuse large B-cell lymphoma. A total of 52.6% of the cases had stage IV disease based on the Ann Arbor staging system. Five-year OS and CSS were 76.9% and 83.4%, respectively. Multivariate analysis revealed that independent predictors of splenic lymphoma CSS included race, stage, chemotherapy, and histological subtype. However, a much shorter OS time was seen in the PSA cohort which had a 5-year OS of 11.8%, a median OS of 10.0\u200amonths and the 5-year CSS of 12.4%. Chemotherapy was correlated with better outcomes in patients with PSA. However, the survival benefits of surgery for splenic cancer were not statistically significant in our study.<\/jats:p>\n                    <jats:p>The current study is the largest cohort of primary splenic cancer presented in literature based on the Surveillance Epidemiology and End Results database and our large series describe the characteristics and survival outcomes of such rare diseases which may provide reliable information for further studies and clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000028539","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:03:07Z","timestamp":1642752187000},"page":"e28539","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Characteristics and survival outcomes of primary splenic cancers"],"prefix":"10.1097","volume":"101","author":[{"given":"Yanna","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.14736","article-title":"Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma","volume":"178","author":"Shimono","year":"2017","journal-title":"Br J Haematol"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbrc.2020.05.145","article-title":"Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress","volume":"528","author":"Wu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R3-20250618","first-page":"3602910","article-title":"Diagnosis of splenic lymphoma by endoscopic ultrasound guided fine needle aspiration: a case report and review of the literature","volume":"2017","author":"Darr","year":"2017","journal-title":"Case Rep Gastrointest Med"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajh.2830380205","article-title":"Primary non-Hodgkin lymphoma of the spleen","volume":"38","author":"Brox","year":"1991","journal-title":"Am J Hematol"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1159\/000493656","article-title":"Clinical characteristics and prognostic factors of primary splenic angiosarcoma: a retrospective clinical analysis from China","volume":"49","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1102\/1470-7330.2010.0026","article-title":"Primary and secondary neoplasms of the spleen","volume":"10","author":"Kaza","year":"2010","journal-title":"Cancer Imaging"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/16078454.2019.1591570","article-title":"Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base","volume":"24","author":"Fallah","year":"2019","journal-title":"Hematology"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/vsu.12405","article-title":"Outcome and prognostic factors for canine splenic lymphoma treated by splenectomy (1995\u20132011)","volume":"44","author":"van Stee","year":"2015","journal-title":"Vet Surg"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00261-018-1542-z","article-title":"18F-FDG PET\/CT in splenic marginal zone lymphoma","volume":"43","author":"Albano","year":"2018","journal-title":"Abdom Radiol"},{"key":"R10-20250618","first-page":"14040","article-title":"Primary splenic angiosarcoma with fever and anemia: a case report and literature review","volume":"8","author":"Deng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/modpathol.3880178","article-title":"Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases","volume":"13","author":"Neuhauser","year":"2000","journal-title":"Mod Pathol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hon.2741","article-title":"The incidence and survival outcomes of patients with primary cardiac lymphoma: a SEER-based analysis","volume":"38","author":"Xiao","year":"2020","journal-title":"Hematol Oncol"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5603\/NMR.2015.0009","article-title":"18F-FDG-PET\/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up","volume":"18","author":"Karunanithi","year":"2015","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1827.2012.02844.x","article-title":"Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases","volume":"62","author":"Shimizu-Kohno","year":"2012","journal-title":"Pathol Int"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.prp.2018.07.021","article-title":"Clinicopathological features of splenic tumours of lymphoid tissue","volume":"214","author":"Chen","year":"2018","journal-title":"Pathol Res Pract"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.21037\/apm-20-1012","article-title":"Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma","volume":"9","author":"Lin","year":"2020","journal-title":"Annals Pall Med"},{"key":"R17-20250618","first-page":"7473935","article-title":"Trends in survival of patients with primary gastric diffuse large B-cell lymphoma: an analysis of 7051 cases in the SEER database","volume":"2018","author":"Liu","year":"2018","journal-title":"Dis Mark"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cam4.1870","article-title":"Trends in survival of patients with stage I\/II Burkitt lymphoma in the United States: a SEER database analysis","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/COC.0000000000000544","article-title":"Epidemiology, tumor characteristics, and survival in patients with primary pancreatic lymphoma: a large population-based study using the SEER database","volume":"42","author":"Mukhija","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1186\/s12889-019-7947-y","article-title":"Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database","volume":"19","author":"Li","year":"2019","journal-title":"BMC Pub Health"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO;2-X","article-title":"Malignant lymphoma of the spleen. a review of 49 cases in which the diagnosis was made at splenectomy","volume":"19","author":"Ahmann","year":"1966","journal-title":"Cancer"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.13320","article-title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","volume":"169","author":"Xing","year":"2015","journal-title":"Br J Haematol"},{"key":"R23-20250618","first-page":"142","article-title":"Primary splenic angiosarcoma: a very rare and aggressive neoplasm with a poor prognosis","volume":"130","author":"Gorzelak-Pabi\u015b","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"R24-20250618","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208956","article-title":"Delayed diagnosis of angiosarcoma of the spleen: clinically presenting as recurrent haemoperitoneum following embolisation","author":"Kornmann","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1067\/j.cpradiol.2015.07.004","article-title":"Primary splenic angiosarcoma: clinical and imaging manifestations of this rare aggressive neoplasm","volume":"45","author":"Batouli","year":"2016","journal-title":"Curr Probl Diagn Radiol"},{"key":"R26-20250618","first-page":"369","article-title":"Primary hemangiosarcoma of the spleen associated with leukocytosis and abnormal spleen scan","volume":"65","author":"Montemayor","year":"1980","journal-title":"Int Surg"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-018-0741-9","article-title":"Simultaneous occurrence of splenic diffuse large B cell lymphoma and gastrointestinal stromal tumor in the stomach: a case report","volume":"13","author":"Chang","year":"2018","journal-title":"Diagn Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:01:37Z","timestamp":1750233697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028539"}},"subtitle":["A SEER population-based study"],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028539","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"2021-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}